세계의 의약품 등급 황산칼슘 시장 보고서(2025년)
Pharma Grade Calcium Sulphate Global Market Report 2025
상품코드 : 1760686
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,444,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,314,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,184,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

의약품 등급 황산칼슘 시장 규모는 향후 몇 년간 강한 성장을 보일 것으로 예상됩니다. 예측 기간에 예상되는 성장은 고령화 인구 증가, 뼈 및 관절 질환의 증가, 신흥 경제국의 의료비 지출 증가, 재생 의학에서 황산칼슘의 사용 증가, 제약 산업의 확장과 같은 요인에 의해 촉진될 것입니다. 예측 기간의 주요 동향으로는 유기 및 천연 황산칼슘 원료로의 전환, 황산칼슘 합성 기술의 발전, 지속 가능성 및 친환경 제조에 대한 관심, 제어 방출 약물 전달 시스템의 개발, 약물 제형 혁신 등이 있습니다.

의약품에 대한 수요가 증가함에 따라 의약품 등급 황산칼슘 시장도 확대될 것으로 예상됩니다. 의약품은 인간과 동물의 질병을 진단, 치료 또는 예방하기 위해 개발된 약품입니다. 의약품에 대한 수요는 만성 질환의 유병률 증가에 의해 크게 촉진되고 있으며, 당뇨병, 심장병, 암과 같은 질환을 관리하기 위해 장기적인 약물을 필요로 하는 사람들이 증가하고 있습니다. 의약품 등급 황산칼슘은 고순도 부형제로 작용하여 일관된 정제 경도, 안정성 및 유효 성분의 제어 방출을 보장함으로써 의약품 제형을 개선합니다. 예를 들어, 2023년 6월, 유럽 제약 산업 및 협회 연맹은 2022년 세계의 제약 매출의 52.3%가 북미에서, 22.4%가 유럽에서 차지했다고 보고했습니다. 그 결과, 의약품에 대한 수요가 증가하면서 의약품 등급 황산칼슘 시장이 성장하고 있습니다.

의약품 등급 황산 칼슘 시장의 기업은 합성 의료용 바사나이트를 활용한 제품 개발에 집중해 황산칼슘의 순도와 일관성을 개선하고 있습니다. 합성 의료용 바사나이트는 황산칼슘(CaSO₄·0.5H₂O)의 고순도 형태로, 의료 및 제약 응용 분야에 적용되는 엄격한 규제 기준을 충족하는 신뢰할 수 있고 오염물질이 없는 원료입니다. 예를 들어, 2025년 2월 인도 스리 치트라 티루날 의과과학기술연구소는 합성 의료용 바사나이트를 사용한 약물 방출형 골 이식재 제품인 Caspro 및 Bonyx를 출시했습니다. 이 제품은 고급 정형외과 응용을 위해 설계되었으며, 높은 순도, 생체적합성, 및 제어된 약물 방출을 보장합니다. Caspro는 골 결손 부위에 사용되는 자체 경화형 성형 가능 골 시멘트이며, Bonyx는 항생제를 함유해 지속적 약물 방출이 가능한 골 유도성 생체 세라믹 구슬로 구성되어 있습니다. 이 제품들은 골 감염 및 재생 치료 분야의 국소 치료에 있어 중요한 진전을 보여주며, 의약품 등급 황산칼슘이 차세대 생체 의학 솔루션에 어떻게 적용될 수 있는지 입증합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별, 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Pharma grade calcium sulphate is a highly purified form of calcium sulphate (CaSO4) that has been specially processed and tested to meet rigorous pharmaceutical standards for use in medicines and healthcare applications. It is commonly used as a diluent or excipient in tablet and capsule formulations because of its high purity, controlled particle size, and non-toxic properties.

The primary types of pharma grade calcium sulphate include calcium sulphate dihydrate (CaSO4*2H2O), calcium sulphate hemihydrate, and calcium sulphate anhydrite. Calcium sulphate dihydrate serves as a pharmaceutical-grade excipient, acting as a binder, carrier, and controlled-release agent in drug formulations. Pharma-grade calcium sulphate has various applications, including use as pharmaceutical excipients, binders in tablets, calcium supplements, and diagnostic agents. It is distributed through several channels such as direct distribution, online sales, wholesale distribution, and retail outlets.

The pharma grade calcium sulphate market research report is one of a series of new reports from The Business Research Company that provides pharma grade calcium sulphate market statistics, including pharma grade calcium sulphate industry global market size, regional shares, competitors with a pharma grade calcium sulphate market share, pharma grade calcium sulphate market segments, market trends, and opportunities, and any further data you may need to thrive in the pharma grade calcium sulphate industry. This pharma grade calcium sulphate market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharma grade calcium sulphate market size has grown strongly in recent years. It will grow from $0.89 billion in 2024 to $0.97 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth observed in the historical period can be linked to the rising demand for pharmaceutical applications, increased use in medical treatments and surgeries, greater awareness of bone health, advancements in drug delivery systems, and a higher incidence of bone-related diseases.

The pharma grade calcium sulphate market size is expected to see strong growth in the next few years. It will grow to $1.36 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth anticipated in the forecast period is driven by factors such as the expanding aging population, the rise in bone and joint disorders, increased healthcare spending in emerging economies, greater use of calcium sulfate in regenerative medicine, and the expansion of the pharmaceutical industry. Key trends for the forecast period include a shift towards organic and natural sources of calcium sulfate, advancements in calcium sulfate synthesis techniques, a focus on sustainability and eco-friendly manufacturing, developments in controlled-release drug delivery systems, and innovations in drug formulations.

The growing demand for pharmaceuticals is expected to drive the expansion of the pharma grade calcium sulphate market. Pharmaceuticals are drugs developed for diagnosing, treating, or preventing diseases in both humans and animals. The demand for pharmaceuticals is largely driven by the increasing prevalence of chronic diseases, with more people needing long-term medications to manage conditions such as diabetes, heart disease, and cancer. Pharma grade calcium sulphate improves pharmaceutical formulations by acting as a high-purity excipient, ensuring consistent tablet hardness, stability, and controlled release of active ingredients. For example, in June 2023, the European Federation of Pharmaceutical Industries and Associations reported that North America accounted for 52.3% of global pharmaceutical sales in 2022, while Europe represented 22.4%. As a result, the rising demand for pharmaceuticals is contributing to the growth of the pharma grade calcium sulphate market.

Companies in the pharma grade calcium sulphate market are focusing on product development using synthetic medical-grade bassanite to improve the purity and consistency of calcium sulphate. Synthetic medical-grade bassanite, a high-purity form of calcium sulphate (CaSO4*0.5H2O), offers a reliable, contaminant-free source that meets strict regulatory standards for use in medical and pharmaceutical applications. For instance, in February 2025, the Sree Chitra Tirunal Institute for Medical Sciences & Technology in India launched Caspro & Bonyx, drug-eluting bone graft products made with synthetic medical-grade bassanite. These products are designed for advanced orthopedic applications and ensure high purity, biocompatibility, and controlled drug delivery. Caspro is a self-setting, mouldable bone cement used for bone defects, while Bonyx consists of osteoconductive bioceramic beads that can be loaded with antibiotics for sustained drug release. These products represent a significant advancement in localized therapy for bone infections and regeneration, showcasing how pharma-grade calcium sulfate can be applied in next-generation biomedical solutions.

In July 2024, Sudeep Pharma Pvt. Ltd., an India-based pharmaceutical company, acquired a 50% stake in JRS Pharma GmbH + Co. KG for an undisclosed amount. This acquisition aims to strengthen Sudeep Pharma's leadership position, accelerate innovation, and expand into emerging pharmaceutical and nutraceutical markets. JRS Pharma GmbH + Co. KG, based in Germany, manufactures Compactrol, a pharmaceutical-grade calcium sulfate product.

Major players in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Honeywell International Inc., Merck KGaA, Solvay S.A., Avantor Inc., MP Biomedicals LLC, Spectrum Chemical Manufacturing Corp., Anhui Sunhere Pharmaceutical Excipients, SRL Chemical, GFS Chemicals Inc., American Elements, Loba Chemie Pvt. Ltd., Annexe Chem, Noah Technologies Corporation, Junsei Chemical Co. Ltd, Nikunj Chemicals, Shiva Inorganics, Huzhou Zhanwang Pharmaceutical Co. Ltd., China Shuanghua Gypsum, Jingmen City Leixin Gypsum.

North America was the largest region in the pharma grade calcium sulphate market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharma grade calcium sulphate report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharma grade calcium sulphate market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharma grade calcium sulphate market consists of sales of USP-grade calcium sulfate dihydrate, anhydrous calcium sulfate, calcium sulfate hemihydrate (medical grade plaster of paris), injectable calcium sulfate pellets, and food or nutraceutical grade calcium sulfate. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharma Grade Calcium Sulphate Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharma grade calcium sulphate market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for pharma grade calcium sulphate ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharma grade calcium sulphate market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Pharma Grade Calcium Sulphate Market Characteristics

3. Pharma Grade Calcium Sulphate Market Trends And Strategies

4. Pharma Grade Calcium Sulphate Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharma Grade Calcium Sulphate Growth Analysis And Strategic Analysis Framework

6. Pharma Grade Calcium Sulphate Market Segmentation

7. Pharma Grade Calcium Sulphate Market Regional And Country Analysis

8. Asia-Pacific Pharma Grade Calcium Sulphate Market

9. China Pharma Grade Calcium Sulphate Market

10. India Pharma Grade Calcium Sulphate Market

11. Japan Pharma Grade Calcium Sulphate Market

12. Australia Pharma Grade Calcium Sulphate Market

13. Indonesia Pharma Grade Calcium Sulphate Market

14. South Korea Pharma Grade Calcium Sulphate Market

15. Western Europe Pharma Grade Calcium Sulphate Market

16. UK Pharma Grade Calcium Sulphate Market

17. Germany Pharma Grade Calcium Sulphate Market

18. France Pharma Grade Calcium Sulphate Market

19. Italy Pharma Grade Calcium Sulphate Market

20. Spain Pharma Grade Calcium Sulphate Market

21. Eastern Europe Pharma Grade Calcium Sulphate Market

22. Russia Pharma Grade Calcium Sulphate Market

23. North America Pharma Grade Calcium Sulphate Market

24. USA Pharma Grade Calcium Sulphate Market

25. Canada Pharma Grade Calcium Sulphate Market

26. South America Pharma Grade Calcium Sulphate Market

27. Brazil Pharma Grade Calcium Sulphate Market

28. Middle East Pharma Grade Calcium Sulphate Market

29. Africa Pharma Grade Calcium Sulphate Market

30. Pharma Grade Calcium Sulphate Market Competitive Landscape And Company Profiles

31. Pharma Grade Calcium Sulphate Market Other Major And Innovative Companies

32. Global Pharma Grade Calcium Sulphate Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharma Grade Calcium Sulphate Market

34. Recent Developments In The Pharma Grade Calcium Sulphate Market

35. Pharma Grade Calcium Sulphate Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기